| RS387907260 |
KCTD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy type 3, Neuronal ceroid lipofuscinosis |
| RS387907261 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS387907262 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS387907263 |
KCTD7
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 3, Progressive myoclonic epilepsy type 3 |
| RS387907264 |
PFN1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 18, Amyotrophic lateral sclerosis type 18 |
| RS387907265 |
PFN1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 18, PFN1-related disorder |
| RS387907266 |
PFN1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 18, Amyotrophic lateral sclerosis type 18 |
| RS387907267 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 4, Cardiovascular phenotype |
| RS387907268 |
PRCD
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 36, Retinitis pigmentosa |
| RS387907269 |
AMER1
|
Health Risk |
Pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS387907270 |
RBPJ
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 3, Adams-Oliver syndrome 3 |
| RS387907271 |
RBPJ
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 3, Adams-Oliver syndrome 3 |
| RS387907273 |
TCTN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofacial-digital syndrome IV, Joubert syndrome 18 |
| RS387907274 |
FUS
|
Health Risk |
Pathogenic |
Tremor, hereditary essential |
| RS387907275 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS387907276 |
SLC3A1
|
Health Risk |
Pathogenic |
Cystinuria, Cystinuria |
| RS387907278 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS387907279 |
FAN1
|
Health Risk |
Pathogenic |
Karyomegalic interstitial nephritis, FAN1-related disorder |
| RS387907280 |
FAN1
|
Health Risk |
Pathogenic |
Karyomegalic interstitial nephritis, Karyomegalic interstitial nephritis |
| RS387907281 |
ATP1A3
|
Health Risk |
Pathogenic |
Alternating hemiplegia of childhood 2, Dystonia 12 |
| RS387907282 |
ATP1A3
|
Health Risk |
Pathogenic |
Alternating hemiplegia of childhood 2, Dystonia 12 |
| RS387907283 |
SMAD6
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS387907285 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS387907286 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS387907287 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS387907288 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia |
| RS387907289 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS387907290 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS387907291 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS387907293 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Leber congenital amaurosis 9 |
| RS387907294 |
NMNAT1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 9, Retinal dystrophy |
| RS387907295 |
SLCO2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS387907296 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS387907297 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS387907298 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Abnormality of the musculature |
| RS387907299 |
POMGNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS387907300 |
POMGNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS387907301 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS387907302 |
KCNV2
|
Health Risk |
Pathogenic |
Cone dystrophy with supernormal rod response, Cone dystrophy with supernormal rod response |
| RS387907303 |
SKI
|
Health Risk |
Pathogenic/Likely pathogenic |
Shprintzen-Goldberg syndrome, Shprintzen-Goldberg syndrome |
| RS387907304 |
SKI
|
Health Risk |
Pathogenic |
Shprintzen-Goldberg syndrome, Inborn genetic diseases |
| RS387907305 |
SKI
|
Health Risk |
Pathogenic |
Shprintzen-Goldberg syndrome, Shprintzen-Goldberg syndrome |
| RS387907306 |
SKI
|
Health Risk |
Pathogenic |
Shprintzen-Goldberg syndrome, Inborn genetic diseases |
| RS387907307 |
TICAM1
|
Health Risk |
risk factor |
Herpes simplex encephalitis, susceptibility to |
| RS387907308 |
NIN
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 7, Seckel syndrome 7 |
| RS387907309 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS387907310 |
CEP164
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS387907311 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS387907312 |
SLC2A1
|
Health Risk |
Pathogenic |
Dystonia 9, GLUT1 deficiency syndrome 1 |
| RS387907313 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, idiopathic generalized |
| RS387907314 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 38, Autosomal recessive retinitis pigmentosa |
| RS387907315 |
ABCD4
|
Health Risk |
Pathogenic |
Methylmalonic acidemia with homocystinuria, type cblJ |
| RS387907316 |
STK4
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to STK4 deficiency, Inherited Immunodeficiency Diseases |
| RS387907317 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS387907319 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS387907320 |
CCDC88C
|
Health Risk |
Pathogenic |
Hydrocephalus, nonsyndromic |
| RS387907321 |
CCDC88C
|
Health Risk |
Likely pathogenic |
Hydrocephalus, nonsyndromic |
| RS387907322 |
CYP24A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercalcemia, infantile |
| RS387907323 |
CYP24A1
|
Health Risk |
Pathogenic |
Hypercalcemia, infantile |
| RS387907324 |
CYP24A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercalcemia, infantile |
| RS387907325 |
FKBP10
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 12, Osteogenesis imperfecta type 12 |
| RS387907326 |
IL10RB
|
Health Risk |
Pathogenic |
Inflammatory bowel disease 25, Inflammatory bowel disease 25 |
| RS387907327 |
ATR
|
Health Risk |
Pathogenic |
Seckel syndrome 1, Seckel syndrome 1 |
| RS387907328 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, See cases |
| RS387907329 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, 6 conditions |
| RS387907330 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS387907331 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS387907332 |
WDR45
|
Health Risk |
Pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS387907333 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS387907334 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS387907335 |
PIKFYVE
|
Health Risk |
Pathogenic |
Fleck corneal dystrophy, Fleck corneal dystrophy |
| RS387907336 |
CRYAB
|
Health Risk |
Pathogenic |
Cataract 16 multiple types, Cataract 16 multiple types |
| RS387907337 |
CRYAB
|
Health Risk |
Pathogenic |
Cataract 16 multiple types, Cataract 16 multiple types |
| RS387907338 |
CRYAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 16 multiple types, Dilated cardiomyopathy 1II |
| RS387907339 |
CRYAB
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 2, Myofibrillar myopathy 2 |
| RS387907340 |
GNB4
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease dominant intermediate F, Charcot-Marie-Tooth disease dominant intermediate F |
| RS387907341 |
GNB4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease dominant intermediate F, Charcot-Marie-Tooth disease dominant intermediate F |
| RS387907342 |
CRYGB
|
Health Risk |
Pathogenic |
Cataract 39 multiple types, Cataract 39 multiple types |
| RS387907343 |
LAMB1
|
Health Risk |
Pathogenic |
Cobblestone lissencephaly without muscular or ocular involvement, Cobblestone lissencephaly without muscular or ocular involvement |
| RS387907344 |
LAMB1
|
Health Risk |
Pathogenic |
Cobblestone lissencephaly without muscular or ocular involvement, Cobblestone lissencephaly without muscular or ocular involvement |
| RS387907345 |
ACTN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Platelet-type bleeding disorder 15, Macrothrombocytopenia |
| RS387907346 |
ACTN1
|
Health Risk |
Pathogenic |
Platelet-type bleeding disorder 15, Platelet-type bleeding disorder 15 |
| RS387907347 |
ACTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet-type bleeding disorder 15, Platelet-type bleeding disorder 15 |
| RS387907348 |
ACTN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Platelet-type bleeding disorder 15, Macrothrombocytopenia |
| RS387907349 |
ACTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS387907350 |
ACTN1
|
Health Risk |
Pathogenic |
Platelet-type bleeding disorder 15, Macrothrombocytopenia |
| RS387907351 |
CARD11
|
Health Risk |
Pathogenic |
BENTA disease, BENTA disease |
| RS387907352 |
CARD11
|
Health Risk |
Pathogenic |
BENTA disease, Severe combined immunodeficiency due to CARD11 deficiency |
| RS387907353 |
WNT1
|
Health Risk |
Pathogenic; risk factor |
Osteogenesis imperfecta type 15, OSTEOPOROSIS |
| RS387907354 |
WNT1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 15, Osteogenesis imperfecta type 15 |
| RS387907355 |
WNT1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 15, Osteogenesis imperfecta type 15 |
| RS387907356 |
WNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 15, Inborn genetic diseases |
| RS387907357 |
WNT1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 15, Osteogenesis imperfecta type 15 |
| RS387907358 |
WNT1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 15, Keratoconus |
| RS387907359 |
WNT1
|
Health Risk |
Likely pathogenic |
OSTEOPOROSIS, EARLY-ONSET |
| RS387907360 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Blepharophimosis - intellectual disability syndrome, MKB type |
| RS387907361 |
MED12
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, MKB type |
| RS387907362 |
MED12
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, MKB type |
| RS387907363 |
SNAP29
|
Health Risk |
Pathogenic |
CEDNIK syndrome, CEDNIK syndrome |
| RS387907364 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |